ArticleMovement disorders clinical practice2025

Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease.

Fabienne Ory-Magne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.